PQ 182
182. Deputy Jonathan O'Brien asked the Minister for Health the medicines that patients with multiple sclerosis have access to through the healthcare system; the difference between medicines that patients here with multiple sclerosis have access to through the healthcare system compared with other European countries; and the average length of time for which persons here with the condition must wait for the delivery and administration of medicines. [47261/18]
Introduced
14 November 2018
Last action
—
Status
written
Sponsors
—
Subjects
Discovery layer
Source updated
14 November 2018
Summary
182. Deputy Jonathan O'Brien asked the Minister for Health the medicines that patients with multiple sclerosis have access to through the healthcare system; the difference between medicines that patients here with multiple sclerosis have access to through the healthcare system compared with other European countries; and the average length of time for which persons here with the condition must wait for the delivery and administration of medicines. [47261/18]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Medicinal Products Reimbursement
Medicinal Products Reimbursement
xml · EN · 14 November 2018
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2018-11-14/182/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2018-11-14/pq_182